Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Tarsus Pharmaceuticals, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Trevejo Jose M. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 1,604 shares @ $18, valued at $28.9k
10/05/2023 144 Form 144 - Report of proposed sale of securities:
08/25/2023 4 Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 8,000 shares @ $17.23, valued at $137.8k
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements XDEMVY™ 0.25% received FDA approval for the treatment for Demodex blepharitis"
08/02/2023 8-K Quarterly results
08/02/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/31/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 4 Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 9,000 shares @ $18.58, valued at $167.2k
06/15/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 4 Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 3,100 shares @ $20.01, valued at $62k
06/12/2023 4 Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 100 shares @ $20, valued at $2k
06/08/2023 4 Mottiwala Aziz (Chief Commercial Officer) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 2,143 shares @ $18.61, valued at $39.9k
Sold 2,500 shares @ $19.34, valued at $48.4k
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 4 Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 8,000 shares @ $15.9, valued at $127.2k
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
05/17/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 4 LINK WILLIAM J PHD (Director) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Disposed of 215,576 shares @ $0
Acquired 41,219 shares @ $0
05/12/2023 4 Azamian Bobak R. (President/CEO and Board Chair) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.
Txns: Sold 9,000 shares @ $16.8, valued at $151.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy